Business
Announces grant of US patent for EpiSwitchT
Announces grant of US patent for EpiSwitchT.
About this update from Oxford Biodynamics Plc
[{"type":"text","content":"\n \nRNS Number : 4610S Oxford BioDynamics PLC 03 October 2017 \n\n \n \n3 October 2017\n \nOxford BioDynamics Plc\n(\"OBD\" or the \"Company\" and, together with its subsidiaries, the \"Group\")\n \nOxford BioDynamics announces grant of US patent for its proprietary technology platform, EpiSwitch™\n \nOxford BioDynamics Plc (\"OBD\" or the \"Company\"), a biotechnology company focused on the discovery and development of epigenetic biomarkers based on regulatory genome architecture, for use within the pharmaceutical and biotechnology industry, today announces the grant of a key patent in the United States by the US Patent and Trademark Office (USPTO) covering EpiSwitch™, the Company's novel technology platform.\n \nThe US patent, number 9777327, covers OBD's proprietary EpiSwitch™ technology designs for high resolution discovery and monitoring of regulatory conditional chromosome conformation signatures, as part of the regulatory genome architecture. As a biomarker modality, chromosome conformations have been shown to deliver highly informative stratifications of complex patient phenotypes, assist in better disease understanding and target identifications, and show high concordance with complex genetic and gene expression profiles. Predictive and prognostic stratifications developed by OBD on the basis of its proprietary EpiSwitchTM technology already offer significant improvements in patient stratifications, significant de-risking of drug discovery and development, and upgraded regulatory and market protection. \n \nThis patent will extend coverage of Oxford BioDynamics' proprietary technology platform, EpiSwitch™, into another important market for the Company. Counterparts to this patent have already been granted in Europe, China, Japan, Australia, Hong Kong, New Zealand, Singapore and South Africa.\n \nChristian Hoyer Millar, CEO of Oxford BioDynamics, commented: \n  ...